Is Adam Worth More Than Eve?

By Goff B.A.   Muntz H.G.   Cain J.M.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 372-377

Elsevier

Access to resources Recommend Favorite

Comparison of 1997 Medicare Relative Value Units for Gender-Specific Procedures: Is Adam Still Worth More Than Eve?

By Goff B.A.   Muntz H.G.   Cain J.M.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite

Atypical protein-kinase Cζ, but neither conventional Ca²⁺-dependent protein-kinase C isoenzymes nor Ca²⁺-calmodulin, participates in regulation of telomerase activity in Burkitt’s lymphoma cells

By Bakalova Rumiana   Ohba Hideki   Zhelev Zhivko   Kubo Takanori   Fujii Masayuki   Ishikawa Mitsuru   Shinohara Yasuo   Baba Yoshinobu  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 161-172

Springer Publishing Company

Access to resources Recommend Favorite

Gynecologic Oncology-On the Eve of the New Millennium

By Podratz K.C.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Exemestane seems to stimulate tumour growth in men with prostate carcinoma

By Bonomo M.   Mingrone W.   Brauchli P.   Hering F.   Goldhirsch A.   for the Swiss Group for Clinical Cancer Cancer Research a.m.o.t.S.I.o.A.C.R.  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2111-2112

Elsevier

Access to resources Recommend Favorite